Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Otlertuzumab Biosimilar – Anti-CD37, TSPAN26 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | VH-V-kappa-CH2-CH3 |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Otlertuzumab Biosimilar - Anti-CD37, TSPAN26 mAb - Research Grade |
|---|---|
| Source | CAS 1372645-37-8 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Otlertuzumab,TRU-016,CD37, TSPAN26,anti-CD37, TSPAN26 |
| Reference | PX-TA1343 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | VH-V-kappa-CH2-CH3 |
| Clonality | Monoclonal Antibody |
Description of Otlertuzumab Biosimilar - Anti-CD37, TSPAN26 mAb - Research Grade
General information on Anti-CD37/TSPAN26[Homo sapiens] (Otlertuzumab) Monoclonal Antibody
Otlertuzumab is investigated for the treatment of chronic lymphocytic leukemia.
Related products
Antigen
C-type lectin domain family 9 member A(CLEC9A)
PX-P4353 217$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.